A method and apparatus for retaining a catheter tip in a fixed position within a blood flow and preventing it from contacting a blood vessel wall. The apparatus includes a tip retainer at the distal end of the catheter that anchors the tip of the catheter within the blood vessel. The catheter tip is retained within the blood vessel spaced from the wall to ensure that it does not contact the wall of the blood vessel. This reduces damage to the blood vessel caused by chronic movement and contact between the catheter tip and the wall of the blood vessel. In one embodiment, the tip retainer includes a prong that penetrates the wall of the blood vessel, thus preventing the catheter tip from moving longitudinally within the blood vessel. In alternative embodiments, the tip retainer contacts the wall but does not penetrate the wall.
|
11. A catheter assembly comprising:
an elongated tube having a first lumen, a second lumen, a first end region, and a second end region; a wire positioned in the second lumen and extending from the first end region to the second end region and being moveable longitudinally in the second lumen, along the length of the tube; a first end of the wire exiting the tube near the second end region; a second end of the wire being connected to the tube at the first end region; and an opening in the second lumen at the first end region through which the wire exists the lumen, the wire extending as a loop from the opening when the first end of the wire is advanced longitudinally along the second lumen.
1. A catheter assembly comprising:
an elongated tube having a first lumen, a proximal end and a distal, the lumen being open at the proximal and distal ends and permitting fluid transport from the distal end inside a body to the proximal end outside the body, a first end region, and a second end region located proximate to the distal end; and a tip retainer assembly coupled at the first end region, the tip retainer assembly including a single loop of wire having a first end and a second end, having one end of the wire coupled to the tube at the first end region and a second end of the wire coupled to the tube at the first end region and the wire extending in a preshaped form that has loop having a selected shape and diameter when at rest.
3. The catheter assembly of
4. The catheter assembly of
5. The catheter assembly of
7. The catheter assembly of
8. The catheter assembly of
9. The catheter assembly of
a channel coupling the second lumen with the silicone tube so that medication can be provided to the silicone tube via the second lumen; and a plurality of apertures in the silicone tube to permit medication within the silicone tube to exit the tube.
13. The catheter assembly of
14. The catheter assembly of
15. The catheter assembly of
|
This patent application is a continuation of U.S. application Ser. No. 08/473,129, filed on Jun. 7, 1995, now U.S. Pat. No. 6,071,263, which is a continuation of U.S. application Ser. No. 08/137,619, filed on Oct. 15, 1993, now U.S. Pat. No. 5,509,900, which is a continuation-in-part of U.S. application Ser. No. 07/844,715, filed on Mar. 2, 1992, now abandoned.
This invention relates to intravascular catheters that have means for reducing stenosis and thrombosis at the tip of the catheter.
The treatment of a number of medical conditions requires the placement of catheters within a patient's blood vessel for an extended period of time. These long-term applications include blood access for hemodialysis, chemotherapy, parental nutrition, blood transfusions and blood sampling.
Vascular access with catheters was first introduced more than 20 years ago. With the advent of soft, flexible silicone double lumen catheters, both acute and chronic hemodialysis became a routine procedure. Although subclavian dialysis catheters are easily inserted and well tolerated, catheter lifespan averages about three months. This is of great concern to patients on maintenance dialysis.
It is well known in the medical field that chronic placement of a catheter in a patient's blood vessel often results in catheter failure due to aspiration of the blood vessel wall into the tip of the catheter, clot or thrombus formation at the tip of the catheter, or stenosis around the tip of the catheter. A catheter failure resulting from one or more of these mechanisms is evidenced by an inability to aspirate and/or infuse fluid through the catheter, generally referred to as catheter occlusion. Typically, catheter occlusions caused by aspiration of the blood vessel wall or clot formation at the catheter tip may be resolved by repositioning the catheter tip or infusing antithrombotic agents.
Stenosis is a narrowing of the blood vessel lumen as seen in a venogram and, in general, can be due to either the formation of a thrombus within the blood vessel or a thickening of the blood vessel wall. The generally accepted view is that stenosis around the tip of a catheter implanted within a blood vessel is due to the formation of a thrombus resulting from a biochemical reaction to the introduction of a foreign material into the blood vessel. Previous attempts to prevent catheter occlusion have centered around thromboresistant coatings on the catheter surface in order to prevent the biochemical reaction of the patient's blood to the material of which the catheter is formed.
Prior art related to the present invention deals with the placement of stents within a diseased blood vessel to treat the problems associated with stenosis. Stents range from simple wire meshes used in U.S. Pat. No. 4,800,882, to a canister made of hydrophilic plastic which expands upon placement in a blood vessel as in U.S. Pat. No. 4,434,797. Stents are typically secured to a deployment catheter for insertion into the patient's blood vessel via a percutaneous procedure. Surgical placement of these stents is achieved by feeding the catheter from a distant site, e.g., a percutaneous puncture into the femoral artery, to the stenosis target. The deployment catheter is then removed, leaving the stent within the blood vessel lumen.
Prior publications on the subject of mounting devices in the blood stream include "Registration of Phoric Changes of Blood Flow by Means of a Catheter-Type Flowmeter," by Heinz Pieper printed in The Review of Scientific Instrument 29(11):965-967, November 1958, and U.S. Pat. Nos. 4,425,908; 4,936,823; 4,813,930; 5,135,517; and 4,654,028. However, none of these address and solve the problems presented in the field of the present invention.
The present invention is directed to an intravascular catheter that has means to retain the tip of the catheter within a blood vessel lumen such that the tip of the catheter is prevented from contacting the wall of the blood vessel. This prevents repeated impact between the catheter tip and blood vessel wall. This reduces denudation and damage to the endothelial and smooth muscle cells that line the blood vessel wall. By reducing damage to these cells, the invention allows for the cells to continue to release the bioactive molecules that normally prevent and reverse the thrombotic and coagulation processes in blood.
Most vascular injury research is in the area of arterial injury; however, the mechanism that regulates cellular growth in injured veins is not known. It is a reasonable assumption that the "response to injury hypotheses" proposed in Ross, R., Glomset, J. A., "The Pathogenesis of Atherosclerosis," N. Engl. J. Med. 295:369-77, 1976, can also be applied to injuries in the venous system. This hypothesis is based on the following observations after injury to the lumen of the blood vessel: (1) platelet adherence and degranulation precedes smooth muscle cell proliferation; (2) intimal thickening in injured arteries of thrombocytopenic animals is reduced; (3) platelet granules contain potent mitogens for cultured smooth muscle cells. Based upon these observations, Ross and Glomset suggested that a high local concentration of growth factors, particularly platelet-derived growth factors released from degranulating platelets could stimulate smooth muscle cell proliferation. Their hypothesis is based on a relationship between the thrombosis that occurs within an injured vessel and the subsequent cell growth associated with repair of the injured vessel wall.
Normally, hemostasis results from a delicate balance between clot-stimulating and clot-inhibiting processes. Endothelial cells and smooth muscle cells in a normal blood vessel are probably the main source of clot regulating factors such as heparin or heparan sulfate. These heparin and heparin-like molecules prevent the adherence of blood proteins and platelets to the surface of a normal blood vessel. Since the endothelium is a critical component of hemostasis control, localized injury and denudation of the endothelium by repeated impact with a catheter tip results in a shift of this delicate balance toward clot and thrombus formation within a denuded region. This clot formation may occur even if the catheter is composed of a material that normally would not create a reaction in the body.
Physical damage to the wall of the blood vessel affects the release and production of a number of growth-stimulating factors such as basic fibroblast growth factor and platelet-derived growth factor. These growth factors help to overcome the antiproliferative activities of the heparan sulfates, thus helping to initiate cellular proliferation and the migration of smooth muscle cells that ultimately leads to stenosis. Therefore, preventing physical damage to the endothelial cell lining of the blood vessel wall reduced stenosis, as well as thrombosis, at the tip of the catheter.
Prior art catheters allow chronic and repeated contact between the catheter tip and the wall of the blood vessel, resulting in damage to the blood vessel as discussed previously. The tip of the catheter may repeatedly bump into different locations inside the blood vessel, or the same location a number of different times, causing a reaction, or worse, damage to the vessel wall. Further damage is caused by the aspiration of the blood vessel wall into the catheter lumen. This occurs when blood is withdrawn through the catheter, such as in the performance of dialysis.
The present invention solves the problems by approaching them from an entirely different view than the prior art attempts; namely, by preventing repeated impact between the catheter tip and the blood vessel wall. The inventor has found that repeated impact with the vessel wall and a catheter tip, even if it is a soft tip, causes a physical reaction in the blood vessel wall. This reaction occurs because of repeated contact between the catheter tip and the wall of the blood vessel even if the catheter tip is soft, and even if the tip is properly coated with antithrombotic agents. This catheter-induced reaction in the blood vessel wall may lead to the formation of a mural thrombus and/or abnormal cellular proliferation within the blood vessel wall, thus resulting in stenosis and catheter occlusion. Prior art efforts to prevent catheter occlusion through the use of thromboresistant coatings do not alleviate the physical reaction that the catheter tip may cause to the blood vessel wall by repeated impact. Therefore, chronic placement of a catheter in a patient still results in catheter occlusion in the majority of cases.
In accordance with aspects of the present invention, chronic contact between and aspiration of the blood vessel wall by the catheter tip is prevented. This reduces damage to the endothelial cells lining the blood vessel, thus reducing catheter occlusion due to stenosis and thrombosis. In addition, the occurrence of catheter occlusion resulting from aspiration of the vessel wall will be reduced.
The present invention includes, in one embodiment, an antistenotic intravascular catheter for insertion into a blood vessel. The catheter includes a tip retainer, located at the distal end of the catheter, for retaining the tip of the catheter within the blood vessel and preventing the catheter from contacting the wall of the blood vessel. The tip retainer positions the tip of the catheter within the blood vessel without substantially obstructing fluid flow through the blood vessel. The catheter also includes an internal passageway for permitting fluids to pass through the catheter. Preferably, the catheter is a double lumen catheter of the type used generally in kidney dialysis.
In all embodiments, the tip of the catheter is retained in the blood vessel by anchoring the tip with respect to the wall of the blood vessel. Advantageously, the tip retainer permits some movement of the catheter tip with respect to the vessel wall, such as slight movement forward and back or side to side with the pulsation of the blood flow. However, movement is restricted to minimize repeated contact (or all contact) of the tip with the blood vessel wall. Just as the anchor of a ship anchors a ship to the bottom but permits some movement of the ship as the water rises and falls or flows, similarly the tip retainer can be said to anchor the tip to the vessel wall but still permit some movement of the tip based on changes of the flow in which it is anchored.
Numerous alternative embodiments are disclosed for the tip retainer. In some embodiments, the tip retainer does not penetrate the wall of the blood vessel. In one embodiment, the tip retainer includes a penetrating member that does penetrate the blood vessel wall. In all embodiments, the tip of the catheter is retained in the blood vessel by anchoring the tip with respect to the wall of the blood vessel.
In one preferred embodiment, the tip retainer is two or more loops of wire that flex outward and contact the wall. The loops do not penetrate the wall tissue, but do anchor the tip in a fixed position in the blood vessel, retaining it in the blood flow and preventing contact of the tip with the vessel walls.
In another preferred embodiment, a single loop extends from the tip portion of a double lumen catheter. The single loop is composed of a flexible wire coated with silicone, silicone tubing or, alternatively, is composed of silicone tubing alone. The diameter of the loop is selected to be sufficiently large that the loop bridges any branches in the blood vessel which are likely to be encountered when the catheter is positioned within the blood vessel.
As a further alternative, the silicone tubing which forms the loop may be in fluid communication with the lumen of the catheter separate from the lumen used for the kidney dialysis. Medication can be delivered through the lumen for delivery to the walls of the blood vessel at the point of contact by the loop. This provides the distinct advantage that anticoagulant medication can be delivered specifically to walls of the blood vessel near the catheter tip.
In a further embodiment the tip retainer includes fletching to anchor the catheter tip in the blood vessel. Alternatively, the tip retainer is a plurality of single straight wires that are prestressed to flex outward or straight wires with loops on the end.
In accordance with one embodiment of the invention, the tip retainer includes penetration means for penetrating the wall of the blood vessel and preventing the tip of the catheter from moving longitudinally within the blood vessel. In this embodiment, the tip includes a loop for limiting the depth of penetration.
In one embodiment of the invention, a plurality of members run from the proximal end of the catheter to the distal end where they extend radially outward until they contact the wall of the blood vessel. In this embodiment, the catheter includes withdrawal means for withdrawing the positioning means into the catheter such that the positioning means is prevented from damaging the wall of the blood vessel when the catheter is withdrawn from the blood vessel, The withdrawal means includes a guideway that runs from the proximal end of the catheter to the distal end of the catheter. The positioning means extends from the proximal end to the distal end of the catheter within the guideway.
According to one aspect of the present invention, a method for reducing catheter failure due to stenosis or thrombosis at a catheter tip is provided. Positioning means is attached to the catheter tip, and the catheter tip and attached positioning means are placed within the blood vessel without substantially obstructing fluid flow through the blood vessel and such that the catheter tip is prevented from contacting the blood vessel wall.
According to one aspect of one embodiment of the present invention, the intravascular catheter 2 includes a tip retainer 9 for retaining the distal end 8 in the bloodstream and preventing the tip of the catheter from contacting the wall of a blood vessel 30 as shown in FIG. 2A.
In a first embodiment, the tip retainer 9 includes four wires 12 positioned within the catheter wall and extending along the length of the catheter, from the distal end of the catheter towards the proximal end 6 of the catheter. This ensures that the proximal ends 34 of the wires 12 will be accessible outside the patient's body after the catheter has been implanted in a blood vessel 30. The proximal ends 34 of the wires 12 are secured to the catheter by an appropriate method such as heat shrink Teflon™ tubing 32 that is placed over the wires and shrunk in place. The proximal end of the wires could also be secured through the use of a band integrally formed in the tube 4 or other structures which prevent movement of the proximal end 34 of the wires 12 until they are controlled by a physician.
The wires 12 are preferably made of or coated with a material which does not cause an adverse reaction when placed in the patient's body. Suitable materials include stainless steel, titanium, some plastics such as nylon, some composite materials, and Teflon™-coated wires, including Teflon™-coated stainless steel. Depending upon the application, the wires 12 have a diameter ranging from 0.0025 to 0.076 cm. In some applications, it may be desirable to treat the wires 12 with an antithrombotic coating, for example, dipping or plating the wires in a coating or applying a coating through plasma polymerization in order to reduce blood clotting on the wires. Plasma polymerization is explained in detail in Yeh et al., "Blood compatibility of surfaces modified by plasma polymerization," Journal of Biomedical Materials Research 22:795-818, 1988.
As shown in
Preferably, the four wires 12 are equally spaced circumferentially around the distal end 8 such that they serve as a tip retainer 9 and positioning means for positioning the tip of the catheter within the blood vessel 30. The tip retainer ensures that the tip of the catheter does not contact the inner wall 27 of the blood vessel 30. The thin wires 12 restrict movement of the tip of the catheter to prevent it from hitting the inner wall 27 while not substantially obstructing the fluid flow through the blood vessel and not causing clots.
In the embodiment illustrated in
Other structures could also be used to perform the penetration and depth limiting functions. As an example, instead of forming a loop near the end of each wire, an enlarged section such as thickening of the wire band welded or bonded to the wire or a bend near the tip of the wire could be used.
The distal end of the catheter is retained within the blood vessel and prevented from contacting the endothelial cells lining the blood vessel by rubbing or aspirating the wall of the blood vessel by the tip retainer 9. Additionally, noncontact damage to the endothelial cells of the blood vessel, such as through fluid dynamics wherein the force of the flow of fluid around the openings of the catheter may cause cellular damage, is believed to be reduced by the present invention. Although penetration of the wall 27 by prongs 26 causes some damage to the blood vessel, the damage caused is not significant in comparison to the damage that would be caused by repeated impact or chronic rubbing of the tip 8 or by aspiration of the inner wall 27, which may occur with prior art catheter designs. By reducing the contact with and damage to the endothelial cells, the present invention allows for the continued release of anticoagulant molecules by the endothelial cells in the vicinity of the distal end of the catheter as explained previously. Correspondingly, there is a reduction in thrombosis and/or stenosis of the blood vessel lumen at the distal end of the catheter and thus reduced catheter occlusion.
The antistenotic intravascular catheter 2 (
Another technique for placing the inventive catheter tip retainer within the blood vessel wall is with an inflatable balloon. Small balloons for insertion into the blood stream and methods to inflate them are known in the field of medical treatment devices. According to one aspect of installing this invention, the wires 12 are positioned circumferentially around such a deflated balloon. The balloon is then introduced into the blood vessel by any acceptable technique. When the tip of the catheter is at the proper location, the balloon is inflated and the wires 12 contact the wall 30. In the embodiment in which prongs 26 are present on the ends of wires 12, the prongs are solidly pressed and embedded into the vessel wall 30 under the force of the balloon. The balloon is then deflated and removed. If this installation technique is used, the wires 12 do not need to be spring-biased outward; the force of the balloon will press them outward into contact with the wall 30.
The catheter 2 is removed from the blood vessel by first removing the heat shrink Teflon™ tubing 32 or other structure which secures the proximal ends 34 of the wires. Each wire 12 is then withdrawn from contact with the blood vessel wall 27 into its respective guide tube 38.
The positioning wires 60 extend radially outward from the securing hoops 64. The wires 60 may be attached to securing hoops 64 by welding, brazing or other appropriate means. In some applications, it may be desirable to treat the wires 60 with an antithrombotic coating to reduce blood clotting on the wires, as explained for the first embodiment. Each wire 60 has a loop 68 formed near the end of the wire, such that a short penetration tip 70 extends outwardly from each loop. The prongs 70 serve as penetration means for penetrating the wall of the blood vessel, while the loops 68 serve as limiting means for limiting the depth of penetration.
This third embodiment of the antistenotic intravascular catheter is inserted into a patient's blood vessel using the same process as described for the first embodiment. Although the third embodiment is structurally simpler than the first embodiment, it requires a more complex procedure in order to remove the catheter from the patient's blood vessel. The third embodiment may be removed using a procedure similar to the catheter insertion procedure described in the first embodiment. A tubular introduction sheath of the type shown in
An indexing mark 76 is also included on the catheter tube 4, extending along the length of the catheter tube 4. The indexing mark 76 visually indicates to a user the rotational orientation of the tip 8 within the blood vessel and thus indicates the rotational orientation of the tip retainer assembly. The position of the indexing mark 76 may indicate, for example, that the rotational orientation of the tip 8 is such that one of the wires 72 is positioned where two of the blood vessels join together and is not contacting any wall of the blood vessel or providing stabilization. The user may then elect to change the rotational orientation of the tip 8 such that each of the wires 72 is firmly in contact with the blood vessel wall. This visualization could also be done, for example, with the catheter positioned within the introducer sheath.
However, one reason for providing at least three and more preferably four wires 72 is because contact with three wires is generally deemed sufficient to stabilize and retain the tip 8 such that it does not contact the wall 27. For example, the catheter 4 having the inventive tip retainer at the distal end 8 may be positioned at or near the brachial cephalic junction and there is a likelihood that one or more of the wires 12 may fall into the junction. One advantage of having multiple wires is that the tip 8 can be stably anchored even if one of the wires is not anchored to the wall because the other wires will hold it in position. Thus, even if one of the wires 72 is not contacting the blood vessel wall because it is positioned in or along the junction, the other wires 72 will be contacting the wall and will retain the tip 8 in a position to prevent it from repeatedly bumping against the inner wall 27 of the blood vessel 30.
In the cloverleaf arrangement of
The wires 82 of loops of
One distinct advantage of the present invention over the prior art is that the catheter end 8 is retained within the flow of the blood and prevented from contacting the wall of the blood vessel without holding the catheter end 8 absolutely rigid. According to some prior art techniques, such as that described in the article of Pieper, as discussed in the background of the invention, the concept is to hold the tip as rigid as absolutely possible. While this may have some benefit in some embodiments, one distinct advantage of the present invention is that the invention will still operate properly even if the tip is permitted to move to different locations within the blood vessel. For example, the tip 8 may move to one side or the other within the blood vessel, based on movement of the patient, or of a rubbing of the blood vessel. Additionally, the tip 8 may move longitudinally, along the direction of the blood flow as the blood pulses. This is desirable in many embodiments and may actually act to relieve some of the stress created by the presence of the catheter. The tip retainer 9 includes members having a light spring force which permits some relative movement between the catheter tip 8 and the wall 27 of the blood vessel. However, the springs have sufficient force that the catheter tip rarely actually contacts the blood vessel wall, thus preventing damage to the blood vessel wall. In some of the embodiments described herein, the spring force becomes stronger as the catheter tip approaches the wall, thus serving to maintain the catheter tip in a spaced relationship from the vessel wall, even if some force is acting on the catheter tip 8 to push it toward the wall. The light spring force at an extended location of the spring permits some catheter tip movement, but as the catheter tip becomes closer to the wall, the spring force gradually increases, making it more difficult for the catheter tip to actually contact the wall. In some embodiments disclosed herein, the spring force is sufficiently strong that as the catheter gets extremely close to the wall, it is forced back with significant pressure to prevent an actual impact with the wall.
As will be appreciated, the tip retainer assembly 9 of each of the embodiments described herein may be made of or coated with an appropriate antithrombotic material that does not cause an adverse reaction when placed within a patient's body, as previously described.
The physician extends or withdraws the wires in the embodiments of
The physician also selects a catheter tip having a properly sized and spring biased tip retainer assembly 9 for his intended uses. If the spring force is found to be too weak, or alternatively, too strong, he may select another tip that is manufactured having a tip assembly 9 of a slightly different spring force, as necessary. (This may be done for each of the embodiments described herein, as desired.) Similarly, a range of loop sizes and shapes is provided to permit the physician to select the one that best suits the needs of a particular use.
The physician may observe the placement and operation of the catheter tip inside the blood vessel to ensure that it is properly anchored as the procedure progresses. This observation can be carried out with known ultrasonic imaging equipment, for example. Alternatively, the tip 8 may have a radioactive isotope or other marker placed therein to permit the physician to ensure that the tip is immobilized and not contacting the vessel wall. A fluoroscope or X-ray device may also be used to image the tip.
Often the tip must be in position in the blood vessel for an extended period. Solid placement of the tip in a position which is spaced from the wall and securely anchored with respect to the wall followed by confirmed observation of this by a physician is thus helpful to permit long-term placement of the catheter without injury to the blood vessel.
To deploy the stent according to the invention, an expandable balloon 162 is positioned near the tip region 8 along the outer wall of the catheter 4, or alternatively, a rolling membrane is provided around the stent 154 and constructed near the catheter tip. The balloon 162 is covered with the self-anchoring stent 154, the entire assembly being attached along the sidewall of the catheter tube 4 when it is inserted into the blood vessel. After the catheter 4 has been inserted into the blood vessel with a tip 8 at the desired location, the balloon 162 is inflated to deploy the stent 154. The stent 154 includes prongs 163 that penetrate the wall of the blood vessel to solidly affix the stent 154 and the catheter end 8 to the wall of the blood vessel. The balloon 162 is then deflated. The stent 154 is connected to the catheter tip 8 by one or more anchoring wires 156, 158, and 160. If desired, to facilitate catheter removal, the prongs 163 may be connected to the stent 154 with prestressed breakaway points so that they may be easily broken off and the stent 154 removed. The prongs 163 may be composed of a material which is absorbed by the body over time. Alternatively, the wires 156, 158, and 160 which connect the tip 8 to the stent 154 may have prestressed breakaway points at the surface of the stent, interfacing between the catheter and the stent 154. The catheter 4 may be removed by withdrawing it, applying pressure to sever the prestressed breakaway points near the surface of the stent 154. In this embodiment, the stent 154 remains within the body and, is preferably constructed of a material which can be absorbed by the body over time rather than being constructed of stainless steel. Materials which can be absorbed by the body are well known in the art and any of those which is commonly known is acceptable for use to construct stent 154 or prongs 163.
According to the embodiment of
By using the techniques according to the concept of this invention, as disclosed in
An advantage of the use of fletching 100 is that the tip retainer 9 is constructed in which the fletching 100 is a plastic or polymer which is injection molded. In one preferred embodiment, the fletching 100 is injection molded or extruded simultaneously with the injection molding or extruding on the tube 4 so that the manufacturing cost is minimized and the entire assembly is provided as a single, unitary member.
According to the embodiment as shown in
In an alternative embodiment the fletchings 100 are positioned such that the tip portion 110 of the fletching 102 that contacts the blood vessel wall is approximately at the end of the tip portion 8 as explained with respect to other alternative embodiments herein.
In one embodiment, the fletching 100 is relatively stiff, so as to slightly stretch the blood vessel and at the particular point of contact create a slight depressed channel in which the fletching rests to anchor the catheter. Preferably, the fletching is not so stiff as to penetrate the wall of the blood vessel but, is sufficiently stiff to prevent excessive undesirable rotation of the tip 8. The upper edge 127 may also be tapered to be thinner in cross section than the lower edge 130 if desired, as explained in more detail with respect to
In the embodiment of
An advantage of the embodiment of
On the other hand, in the alternative embodiment of
It is contemplated, for example, that in one embodiment a thin wire 139, such as the type shown in
For example, as best shown in
The tapered fletching provides the additional advantage that a preformed tip assembly 9 can be used in many sizes of blood vessels. A single blood vessel may have a large inner diameter lumen at one region and a small inner diameter lumen in a different region. The difference in diameter may be caused by localized thickening of the walls, injury, fatty build up, or other causes. When the catheter is placed in the vessel, the physician may not be aware of the exact diameter of the blood vessel at the desired location (even though it might be measured ultrasonically, for example). The physician is assured that the catheter tip will be properly retained in the blood flow and spaced from the wall even if the exact dimensions are not as was expected at the installation site. (This advantage is provided in other embodiments also, such as the embodiments of
Having tapered edges provides another distinct advantage: the relative flexibility and spring bias within the fletching may be easily altered along the fletching as it extends outward. That is, at the very edge of the fletching near rounded portion 140, the resilient bias can be very light because the fletching is very thin at the edges. Closer to the base, the fletching gradually becomes thicker, naturally increasing the spring strength and resilient bias within the fletching. This has the advantage of increasing the centering ability of the tubing 4 because if the tubing begins to be pressed out of position, towards one wall the fletching on that side of the tubing will have the base region pressed closer to the wall; however, the base region being thicker and having a stronger spring action will tend to increase the resilient bias away from the wall to push with more force away from the wall and tend to center the tubing 4 within the blood vessel. Each of the fletchings are constructed with uniform spring bias to act together in generally centering the tubing 4 within the blood vessel and prevent the tubing from becoming too close to the blood vessel wall on any side.
In one embodiment, the spring strength of the fletching varies proportional to the thickness of the fletching. In an alternative embodiment, the fletching is constructed such that the spring bias is not uniform with respect to the thickness of the fletching. For example, a relatively strong spring bias can be placed adjacent the base, even more than would otherwise be present, to ensure that the tubing 4 is always spaced at least a minimum distance from the wall 27. Alternatively, a slightly stronger spring bias may be placed right at the tip 140 than would otherwise be present based on the edges being extremely thin because the edges may be so thin as to have little or no spring bias based on their own thickness. In such an embodiment, the properties of the material or the type of material used may be slightly altered at the very tip region 140 to provide sufficient spring strength to anchor the end even though the tip portions are extremely thin.
The fletching as illustrated in
The insertion and removal of the catheter tubing 4 having the tip retainer on the end thereof will now be explained in particular detail with respect to
Referring now to
As shown in
As shown in
In an alternative embodiment, the sheath is simply removed by sliding it backwards, rather than tearing the sheath into two pieces. As will be appreciated, tearing the sheath into two separate pieces provides the distinct advantage of permitting the introducer sheath to be easily separated from a portion of the tubing without having to completely slide off the end of the tubing outside the body. It also provides the advantage that the physician may easily and uniformly withdraw the introducer sheath while leaving the tubing 4 in the preset position, to permit the tip retainer to be deployed to retain the tip portion 8 in the desired position within the blood vessel.
Removal of the catheter 4 having the tip retainer 9 on the end thereof is easily accomplished with each of the alternative embodiments. In the alternative embodiments of
According to an alternative embodiment, the tip retainer is withdrawn from the deployed position so as to not contact the wall by sliding an introducer sheath once more over the tip portion 8 to withdraw the tip retainer 9 from the blood vessel wall. The sheath and catheter tube 4 may then be withdrawn from the blood vessel.
The size of the loop 168 is selected based on the size of the blood vessel and position placement of the catheter 4 in that blood vessel. In one embodiment, the loop 168 has a diameter of 20 millimeters and the ends 162 and 164 are connected to the tip portion 8 spaced from the tip portion 8 approximately 7 millimeters. In other alternative embodiments, the diameter of the loop 168 is considerably smaller, in order to be properly sized for placement in the selected vessel of the human body during a kidney dialysis or other procedure, as explained herein.
The ends of the loop 168 are fixed to the catheter 4 by any suitable technique including silicone adhesive, forming an incision in the tubing 4 and insertion into this incision followed by sealing with silicone adhesion, or the like.
The diameter and spring strength of the steel wire 166 is selected to provide the desired spring force to urge the loop 168 to return to the round position as shown in FIG. 25. Generally, a relatively light spring force is acceptable as would be provided small diameter wire 166. Other materials besides stainless steel, such as various alloys of steel, spring steel, teflon coated steel, and the like are also acceptable. The silicone tubing 160 is provided as antithrombogenic coating which is easily manufactured attached to the catheter 4. Any other acceptable antithrombogenic coating besides the silicone tubing 160 could also be used, such as the antithrombogenic coatings described with respect to the other embodiments herein.
In one embodiment, the wire 166 is not present. Instead, only the silicone tubing at 160 is used to form the loop 168 because the proper spring constant is provided from the natural spring within the silicone tubing itself.
The loop 168 is preferably constructed of a small diameter material, such as a silicone tubing having an outside diameter of 1 millimeter or less or a wire having an outside diameter of 0.5 millimeters or less. Using a small diameter material to construct the loop 168 provides the advantage that blood flow through the main blood vessel 30 is not impeded by the tip retaining member 9. If the tip portion 8 happens to be positioned adjacent a junction 170, the additional advantage is that blood flow into or out of the blood vessel 30' that junctions with the blood vessel 30 is not impeded by the loop 168 bridging the junction 170 between the blood vessels. Even if the loop 168 is positioned directly over the opening of 30' at the junction itself, the loop diameter is sufficiently small that blood may easily flow through the blood vessel 30' as needed.
The operation of the device of embodiments 25-27 is as follows. The catheter 4 is positioned in the blood vessel using any acceptable delivery system. The delivery system of the type shown and described with respect to
At the conclusion of the medical procedure, the catheter 4 is simply withdrawn by being retracted it while leaving the loop 168 in the deployed position. Alternatively, a retraction sheath may be placed around the catheter 4 which slides along the outer diameter of catheter 4 and compresses the loop 160 to move it away from the wall of the blood vessel similar to that shown in the introduction position of FIG. 23. The catheter 4 is then removed.
The tubing 160 contains a plurality of apertures 180 spaced from each other around the loop 168. In one embodiment, the apertures 180 are equally spaced from each other around the entire loop. Alternatively, the apertures 180 are positioned only along the side portions of the loop 168, which are anticipated to contact the wall 27 of the blood vessel as shown in FIG. 27. The very tip region 182 of the loop does not contain any apertures in this alternative embodiment.
Medication can then be delivered through the lumen 178, into the loop 168 constructed from the hollow tubing 160 and exit the apertures 180 for administration to the patient. The silicone tube 160 thus becomes a medication delivery system. When the catheter is positioned for an extended time within the human body, as may occur with kidney dialysis, it is known in the art that smooth muscle cell growth, platelet aggregation, and the like to deliver medication may occur. The use of a tip retainer to deliver medication constructed according to principles of the present invention minimizes occlusion of the blood vessel, and reduces destruction of the blood vessel by delivering specific anti-clotting agents to the tip region 8 via the apertures 180 in the loop 168. It is known in the art that the smooth muscle walls surrounding the blood vessel are inhibited from excessive growth by certain medications. One of the problems identified according to principles of the present invention and which the invention seeks to prevent is excessive growth of the smooth muscles around the blood vessel wall which may overgrow into and cause occlusion of the blood vessel 30. The medication delivery system as illustrated in FIG. 29 and described herein advantageously delivers medication precisely to the location desired for inhibiting excessive growth of the muscle cells around the blood vessel wall and for inhibiting platelet aggregation along the wall of the blood vessel or other clotting along the walls of the blood vessel. The medications which may delivered include TPA, an anticlotting agent; strepokinase, heparin, hirudin, or the like. In some instances, clotting beings to occur along the walls 27 of the blood vessel 30. The loop 168 is in actual contact with the blood vessel wall 27. The medication can therefore be delivered directly to the wall of the blood vessel with benefits obtained in addition to those which may be obtained by delivering the same medication exiting from the main lumen 28 of the catheter.
The position, size and relative location of the apertures 180 are selected to provide the desired delivery medication. In some embodiments, having the apertures 180 spaced equidistance from each other and opening to both the inside and outside of the loop 168 is desirable to provide medication equally around the loop 168. In an alternative embodiment, the apertures 180 are spaced only on an outside surface of the loop 168 to deliver the medication outward from the loop. In a further alternative embodiment, the apertures 180 are positioned only at or near locations which are anticipated to come in contact with the wall 27 of the blood vessel 30. The apertures 180 may be oriented to discharge the medication along the surface of the blood vessel wall 27 and thus are radially offset from the outside position to deliver the medication adjacent the wall 27 so that the wall 27 does not block outflow of the medication.
Having the tubing 160 or, alternatively, a wire 166 within the tubing 160 extend to the proximal end of the catheter 4 provides the additional advantage that the loop 168 may be retracted or extended as necessary. When the catheter 4 is inserted into the patient, the loop 168 can be in a retracted, small diameter position held tightly against the tip portion 8. Once the catheter is at the proper location, the wire 166, if present, or alternatively the tubing 160, may be pushed along the lumen 178 to enlarge the loop 168 to a size and shape as described with respect to FIG. 27. The loop 168 thereafter remains in the extended position during the medical procedure. At the conclusion of the medical procedure, the wire 166, or alternatively the lumen 160, are retracted down the lumen 178 to again reduce the diameter of the loop 168. The loop 168 may also be retracted or extended using the lumens 172 and 174 of the catheter of FIG. 28C. The catheter 4 is then withdrawn from the patient. Alternatively, a delivery system of the type described with respect to
The triangular members 182 and 184 include respective apertures 185. The apertures 185 advantageously permit the spring constant of the triangular members 182 to be selected by making the aperture small or large to provide a correspondingly large or small spring constant as desired. Further, the apertures may also provide the benefit of the triangular members 182 and 184 minimizing interference with the flow of blood.
Constructing the triangular members 182, 184 from a strip of silicone provides the advantage previously described with respect to the loop 168 that blood flow through the blood vessels 30 or 30' is not impeded with the catheter 4 in position. Flow to or from the branch at the junction is not restricted.
While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
Patent | Priority | Assignee | Title |
10085753, | Jul 01 2005 | Abbott Laboratories | Clip applier and methods of use |
10111664, | Jan 05 2000 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
10130385, | Jun 26 2007 | ROXWOOD MEDICAL INC. | Method and apparatus for placing a catheter within a vasculature |
10130795, | Jun 26 2007 | ROXWOOD MEDICAL INC. | Catheter apparatus with telescoping lumen catheters and its use in methods for treating vasculatures |
10136907, | Aug 01 2013 | Cook Medical Technologies LLC | Methods of locating and treating tissue in a wall defining a bodily passage |
10195398, | Aug 13 2014 | Cook Medical Technologies LLC | Tension member seal and securing mechanism for medical devices |
10201340, | Feb 21 2002 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
10201441, | Oct 30 2002 | Boston Scientific Scimed, Inc. | Linearly expandable ureteral stent |
10245013, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
10342565, | Apr 24 2013 | Hologic, Inc. | Surgical system with expandable shield |
10350397, | Nov 22 2010 | Aria CV, Inc. | System and method for reducing pulsatile pressure |
10398418, | Jan 30 2003 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
10413295, | May 16 2008 | Abbott Laboratories | Engaging element for engaging tissue |
10426510, | Oct 22 2012 | ROXWOOD MEDICAL, INC. | Method and apparatus for centering a microcatheter within a vasculature |
10471234, | Jun 26 2007 | ROXWOOD MEDICAL, INC. | Catheter apparatus and methods for treating vasculatures |
10507013, | Apr 09 2012 | Abbott Cardiovascular Systems, Inc. | Closure devices, systems, and methods |
10537312, | Dec 21 2012 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
10537313, | Jan 09 2009 | Abbott Vascular, Inc. | Closure devices and methods |
10582937, | Oct 24 2016 | Medical guide wire device for endovascular-intraluminal devices | |
10596354, | Sep 25 2015 | Guide wires, catheters, and guide wire catheter systems and methods | |
10617538, | Jun 08 2010 | Regents of the University of Minnesota | Vascular elastance |
10682448, | Jun 19 2014 | Aria CV, Inc. | Systems and methods for treating pulmonary hypertension |
10702682, | Nov 22 2010 | Aria CV, Inc. | System and method for reducing pulsatile pressure |
10751519, | Nov 22 2010 | Aria CV, Inc. | System and method for reducing pulsatile pressure |
10806439, | Oct 11 2013 | Abbott Cardiovascular Systems, Inc. | Suture-based closure with hemostatic tract plug |
10814098, | Feb 28 2014 | Cook Medical Technologies LLC | Deflectable catheters, systems, and methods for the visualization and treatment of bodily passages |
10918373, | Aug 31 2013 | Edwards Lifesciences Corporation | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
11065028, | Jun 26 2007 | ROXWOOD MEDICAL INC. | Method and apparatus for placing a catheter within a vasculature |
11141581, | Sep 06 2019 | Aria CV, Inc. | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure |
11331105, | Oct 19 2016 | Aria CV, Inc. | Diffusion resistant implantable devices for reducing pulsatile pressure |
11344304, | Jul 01 2005 | Abbott Laboratories | Clip applier and methods of use |
11406803, | Nov 22 2010 | Aria CV, Inc. | System and method for reducing pulsatile pressure |
11439378, | Jan 09 2009 | Abbott Cardiovascular Systems, Inc. | Closure devices and methods |
11511089, | Jun 19 2014 | Aria CV, Inc. | Systems and methods for treating pulmonary hypertension |
11529497, | Jan 13 2022 | Orlando Health, Inc. | Centering device for a catheter |
11583420, | Jun 08 2010 | Regents of the University of Minnesota | Vascular elastance |
11589856, | Jan 30 2003 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
11666315, | Oct 11 2013 | Abbott Cardiovascular Systems, Inc. | Suture-based closure with hemostatic tract plug |
11672518, | Dec 21 2012 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
11833343, | Sep 06 2019 | Aria CV, Inc. | Diffusion and infusion resistant implantable devices for reducing pulsatile pressure |
6767339, | Dec 12 1997 | Cook Medical Technologies LLC | Body canal intrusion instrumentation having bidirectional coefficient of surface friction with body tissue |
7232462, | Mar 31 2004 | Cook Medical Technologies LLC | Self centering delivery catheter |
7465286, | Mar 03 2004 | C R BARD, INC | Loop-tip catheter |
7547303, | Aug 03 2006 | Boston Scientific Scimed, Inc. | Catheter assembly including foldable internal bolster |
7722596, | Feb 26 2004 | V-KARDIA INC ; OSPREY MEDICAL INC | Regional cardiac tissue treatment |
7753868, | Aug 21 2007 | Cook Medical Technologies LLC | Multi-lumen catheter |
7799050, | May 05 2004 | Lifescreen Sciences LLC | Devices and methods for magnetically manipulating intravascular devices |
7909862, | Mar 19 2003 | Cook Medical Technologies LLC | Delivery systems and methods for deploying expandable intraluminal medical devices |
7922687, | Nov 17 2003 | Cook Medical Technologies LLC | Catheter with centering wire |
7996976, | Mar 25 2003 | Boston Scientific Scimed, Inc. | Retaining stent |
8002729, | Aug 21 2007 | Cook Medical Technologies LLC | Multi-lumen catheter assembly |
8002764, | May 01 2003 | SWAN VALLEY MEDICAL INCORPORATED | Cystotomy catheter capture device and methods of using same |
8007702, | Oct 30 2002 | Boston Scientific Scimed, Inc. | Methods of manufacturing linearly expandable ureteral stents |
8016815, | Aug 03 2006 | Boston Scientific Scimed, Inc. | Catheter assembly including foldable internal bolster |
8057424, | Mar 03 2004 | C R BARD, INC | Loop-tip catheter |
8118736, | Sep 27 2007 | Swan Valley Medical, Incorporated | Method of accessing a bladder and associated apparatus therefor |
8118826, | Sep 27 2007 | Swan Valley Medical, Incorporated | Method of performing a suprapubic transurethral cystostomy and associated procedures and apparatus therefor |
8241548, | Oct 30 2002 | Boston Scientific Scimed, Inc. | Methods of manufacturing linearly expandable ureteral stents |
8292871, | Feb 26 2004 | Osprey Medical, Inc. | Regional cardiac tissue treatment |
8308673, | Jun 13 2007 | CATHAROS MEDICAL SYSTEMS INC | Methods and devices for removal of a medical agent from a physiological efferent fluid collection site |
8382785, | Sep 27 2007 | SWAN VALLEY MEDICAL INCORPORATED | Apparatus and method for performing cystotomy procedures |
8398656, | Jan 30 2003 | INTEGRATED VASCULAR SYSTEMS, INC | Clip applier and methods of use |
8403977, | May 04 2006 | Cook Medical Technologies LLC | Self-orienting delivery system |
8409161, | Aug 12 2008 | Osprey Medical, Inc. | Remote sensing catheter system and methods |
8454650, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
8469995, | Jun 04 2002 | ABBOTT VASCULAR INC. | Blood vessel closure clip and delivery device |
8486092, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
8486108, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
8496607, | Dec 04 2009 | Cook Medical Technologies LLC | Multi-lumen catheter |
8518057, | Jul 01 2005 | Abbott Laboratories | Clip applier and methods of use |
8529587, | Jan 30 2003 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
8545434, | Oct 26 2006 | Cook Medical Technologies LLC | Catheter port configuration |
8556930, | Jun 28 2006 | Abbott Laboratories | Vessel closure device |
8568643, | Oct 30 2002 | Boston Scientific Scimed, Inc. | Methods of manufacturing linearly expandable ureteral stents |
8574221, | Sep 09 2011 | Cook Medical Technologies LLC | Tubular medical device |
8579932, | Feb 21 2002 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
8585836, | Dec 31 2002 | Integrated Vascular Systems, Inc. | Methods for manufacturing a clip and clip |
8590760, | May 25 2004 | Abbott Vascular Inc | Surgical stapler |
8597325, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
8603116, | Aug 04 2010 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
8603136, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
8617117, | Oct 08 2008 | ACROSTAK CORP | Medical tubing assembly to facilitate tube fixation |
8628494, | Jul 20 2009 | ASTORA WOMEN S HEALTH HOLDINGS, LLC | Devices, systems, and methods for delivering fluid to tissue |
8657852, | Oct 30 2008 | ABBOTT VASCULAR INC. | Closure device |
8672953, | Dec 17 2007 | Abbott Laboratories | Tissue closure system and methods of use |
8690910, | Dec 07 2000 | INTEGRATED VASCULAR SYSTEMS, INC | Closure device and methods for making and using them |
8702679, | Jun 10 2003 | CARDINAL HEALTH SWITZERLAND 515 GMBH | Catheter systems and methods for crossing vascular occlusions |
8708986, | Nov 07 2006 | Osprey Medical Inc. | Collection catheter and kit |
8728119, | Jun 07 2001 | ABBOTT VASCULAR INC. | Surgical staple |
8747386, | Dec 16 2010 | Boston Scientific Scimed, Inc | Anastomosis device and related methods |
8758396, | Jan 05 2000 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
8758398, | Sep 08 2006 | INTEGRATED VASCULAR SYSTEMS, INC | Apparatus and method for delivering a closure element |
8758399, | Aug 02 2010 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
8758400, | Jan 05 2000 | INTEGRATED VASCULAR SYSTEMS, INC | Closure system and methods of use |
8784447, | Sep 08 2000 | Abbott Vascular Inc | Surgical stapler |
8808310, | Apr 20 2006 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
8820602, | Dec 18 2007 | Abbott Laboratories | Modular clip applier |
8821534, | Dec 06 2010 | INTEGRATED VASCULAR SYSTEMS, INC | Clip applier having improved hemostasis and methods of use |
8858594, | Dec 22 2008 | Abbott Laboratories | Curved closure device |
8893947, | Dec 17 2007 | Abbott Laboratories | Clip applier and methods of use |
8905937, | Feb 26 2009 | INTEGRATED VASCULAR SYSTEMS, INC | Methods and apparatus for locating a surface of a body lumen |
8920363, | Mar 03 2004 | C. R. Bard, Inc. | Loop-tip catheter |
8926633, | Jun 24 2005 | Abbott Laboratories | Apparatus and method for delivering a closure element |
8926656, | Jan 30 2003 | Integated Vascular Systems, Inc. | Clip applier and methods of use |
8956388, | Jan 05 2000 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant |
8974475, | Apr 30 2010 | Medtronic, Inc. | Methods and devices for cardiac valve repair or replacement |
9033917, | Aug 15 2012 | Abbott Cardiovascular Systems Inc. | Needle catheter for delivery of agents directly into vessel wall |
9050068, | Jul 01 2005 | Abbott Laboratories | Clip applier and methods of use |
9050087, | Jan 05 2000 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
9050400, | Aug 12 2008 | OSPREY MEDICAL, INC | Remote sensing catheter system and methods |
9060769, | Sep 08 2000 | ABBOTT VASCULAR INC. | Surgical stapler |
9060888, | Oct 30 2002 | Boston Scientific Scimed, Inc. | Method of disposing a linearly expandable ureteral stent within a patient |
9089311, | Jan 09 2009 | ABBOTT VASCULAR INC. | Vessel closure devices and methods |
9089674, | Oct 06 2000 | Integrated Vascular Systems, Inc. | Apparatus and methods for positioning a vascular sheath |
9149276, | Mar 21 2011 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
9173644, | Jan 09 2009 | ABBOTT VASCULAR INC. | Closure devices, systems, and methods |
9192710, | Dec 04 2009 | Cook Medical Technologies LLC | Multi-lumen catheter |
9211372, | Aug 11 2011 | Osprey Medical, Inc. | Systems and methods for limb treatment |
9241696, | Oct 30 2008 | Abbott Vascular Inc | Closure device |
9242082, | Jun 19 2014 | Aria CV, Inc. | Systems and methods for treating pulmonary hypertension |
9248253, | Aug 21 2007 | Cook Medical Technologies LLC | Winged catheter assembly |
9254203, | Aug 20 2012 | Boston Scientific Scimed, Inc. | Delivery device |
9271707, | Jan 30 2003 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
9271752, | Mar 13 2013 | SWAN VALLEY MEDICAL INCORPORATED | Method and apparatus for placing a cannula in a bladder |
9282965, | May 16 2008 | Abbott Laboratories | Apparatus and methods for engaging tissue |
9295469, | Jun 04 2002 | ABBOTT VASCULAR INC. | Blood vessel closure clip and delivery device |
9295816, | Dec 09 2009 | OSPREY MEDICAL, INC | Catheter with distal and proximal ports |
9314230, | Jan 09 2009 | ABBOTT VASCULAR INC. | Closure device with rapidly eroding anchor |
9320522, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
9332976, | Nov 30 2011 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
9333328, | Nov 22 2010 | ARIA CV, INC | System and method for reducing pulsatile pressure |
9364209, | Dec 21 2012 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
9364615, | Jul 20 2009 | ASTORA WOMEN S HEALTH HOLDINGS, LLC | Devices, systems, and methods for delivering fluid to tissue |
9398914, | Jan 30 2003 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
9402625, | Sep 08 2000 | ABBOTT VASCULAR INC. | Surgical stapler |
9414820, | Jan 09 2009 | ABBOTT VASCULAR INC. | Closure devices, systems, and methods |
9414824, | Jan 16 2009 | ABBOTT VASCULAR INC. | Closure devices, systems, and methods |
9421017, | Jan 15 2014 | Methods and apparatus using branched balloon for treating pulmonary arterial hypertension | |
9421316, | May 04 2010 | LXS, LLC | Apparatus and methods for accessing the lymphatic system |
9427236, | Jan 31 2014 | Methods and apparatus using an anchored balloon for treating pulmonary arterial hypertension | |
9456814, | Apr 09 2012 | Abbott Cardiovascular Systems, Inc. | Closure devices, systems, and methods |
9486191, | Jan 09 2009 | ABBOTT VASCULAR, INC | Closure devices |
9498196, | Feb 21 2002 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
9549748, | Aug 01 2013 | Cook Medical Technologies LLC | Methods of locating and treating tissue in a wall defining a bodily passage |
9554786, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
9555183, | Aug 11 2011 | Osprey Medical, Inc. | Systems and methods for limb treatment |
9579091, | Jan 05 2000 | INTEGRATED VASCULAR SYSTEMS, INC | Closure system and methods of use |
9585646, | Dec 07 2000 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
9585647, | Aug 26 2009 | Abbott Laboratories | Medical device for repairing a fistula |
9610391, | Jun 19 2014 | Aria CV, Inc. | Systems comprising an implantable component for treating pulmonary hypertension |
9675759, | Jul 20 2009 | Astora Women's Health Holdings, LLC | Devices, systems, and methods for delivering fluid to tissue |
9801989, | Jun 19 2014 | Aria CV, Inc. | Systems and methods for treating pulmonary hypertension |
9833130, | Jul 22 2011 | Cook Medical Technologies LLC | Irrigation devices adapted to be used with a light source for the identification and treatment of bodily passages |
9895055, | Feb 28 2013 | Cook Medical Technologies LLC | Medical devices, systems, and methods for the visualization and treatment of bodily passages |
9937323, | Feb 28 2014 | Cook Medical Technologies LLC | Deflectable catheters, systems, and methods for the visualization and treatment of bodily passages |
9962144, | Jun 28 2006 | Abbott Laboratories | Vessel closure device |
9980631, | Jul 22 2011 | Cook Medical Technologies LLC | Irrigation devices adapted to be used with a light source for the identification and treatment of bodily passages |
9980728, | Jun 04 2002 | Abbott Vascular Inc | Blood vessel closure clip and delivery device |
9987153, | Jun 08 2010 | Regents of the University of Minnesota | Vascular elastance |
D622379, | Apr 24 2009 | Percuvision LLC | Catheter |
Patent | Priority | Assignee | Title |
2541691, | |||
2701559, | |||
3108595, | |||
3866599, | |||
4425908, | Oct 22 1981 | NITINOL MEDICAL TECHNOLGIES, INC , 7779 WILLOW GLEN ROAD, LOS ANGELES, CA 90046, A DE CORP | Blood clot filter |
4434797, | Jan 12 1979 | AB Tesi | Catheter |
4643184, | Sep 29 1982 | Embolus trap | |
4654028, | Mar 14 1985 | Incision opening expansion holder for inosculation | |
4669464, | Mar 06 1984 | Surgical instrument for transjugular venous thromboectomy | |
4727873, | Sep 29 1982 | Embolus trap | |
4733669, | May 24 1985 | Volcano Corporation | Blood flow measurement catheter |
4800882, | Mar 13 1987 | Cook Incorporated | Endovascular stent and delivery system |
4813930, | Oct 13 1987 | DIMED, INCORPORATED, 2018 BROOKWOOD MEDICAL CENTER DRIVE, SUITE 305 BIRMINGHAM JEFFERSON ALABAMA 35209 A CORP OF ALABAMA | Angioplasty guiding catheters and methods for performing angioplasty |
4909781, | Apr 08 1988 | Catheter with flexible cutter | |
4909789, | Mar 28 1986 | Olympus Optical Co., Ltd. | Observation assisting forceps |
4921484, | Jul 25 1988 | Cordis Corporation | Mesh balloon catheter device |
4936823, | May 04 1988 | PYRAMID TECHNOLOGIES INTERNATIONAL, INC | Transendoscopic implant capsule |
4944745, | Feb 29 1988 | Boston Scientific Scimed, Inc | Perfusion balloon catheter |
4957484, | Jul 26 1988 | Automedix Sciences, Inc. | Lymph access catheters and methods of administration |
4990156, | Jun 21 1988 | Filter for medical use | |
4998975, | Oct 30 1989 | Pacesetter, Inc | Travenously placed defibrillation leads |
5041093, | Jan 31 1990 | Boston Scientific Scimed, Inc | Catheter with foraminous anchor |
5053008, | Nov 21 1990 | Intracardiac catheter | |
5098440, | Aug 14 1990 | Cordis Corporation | Object retrieval method and apparatus |
5112347, | May 14 1991 | TRACKS, INC | Embolectomy catheter, and method of operating same |
5122125, | Apr 25 1990 | Ashridge A.G. | Catheter for angioplasty with soft centering tip |
5135517, | Jul 19 1990 | CATHETER RESEARCH, INC , A CORP OF IN | Expandable tube-positioning apparatus |
5152777, | Jan 25 1989 | Uresil, LLC | Device and method for providing protection from emboli and preventing occulsion of blood vessels |
5167634, | Aug 22 1991 | Datascope Investment Corp. | Peelable sheath with hub connector |
5180368, | Apr 08 1991 | Advanced Cardiovascular Systems, Inc. | Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels |
5256146, | Oct 11 1991 | ENSMINGER, WILLIAM D ; ANDREWS, JAMES C ; KNOL, JAMES A | Vascular catheterization system with catheter anchoring feature |
5267960, | Mar 19 1990 | Advanced Cardiovascular Systems, INC | Tissue engaging catheter for a radioactive source wire |
5275610, | May 13 1991 | Cook Medical Technologies LLC | Surgical retractors and method of use |
EP364293, | |||
WO8900834, | |||
WO9306885, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Date | Maintenance Fee Events |
Nov 06 2006 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Dec 13 2010 | REM: Maintenance Fee Reminder Mailed. |
May 06 2011 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
May 06 2006 | 4 years fee payment window open |
Nov 06 2006 | 6 months grace period start (w surcharge) |
May 06 2007 | patent expiry (for year 4) |
May 06 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
May 06 2010 | 8 years fee payment window open |
Nov 06 2010 | 6 months grace period start (w surcharge) |
May 06 2011 | patent expiry (for year 8) |
May 06 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
May 06 2014 | 12 years fee payment window open |
Nov 06 2014 | 6 months grace period start (w surcharge) |
May 06 2015 | patent expiry (for year 12) |
May 06 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |